Findings from New York University (NYU) Langone Health Provide New Insights into Hypertrophic Cardiomyopathy (Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated...).

A recent study conducted at New York University (NYU) Langone Health focused on the use of disopyramide in treating heart failure symptoms in patients with obstructive hypertrophic cardiomyopathy (HCM). The research involved 92 patients with symptomatic obstructive HCM who were maintained on disopyramide for over 5 years, showing that the medication was effective in reducing outflow obstruction and relieving heart failure symptoms in a subgroup of patients. The study concluded that disopyramide is safe and effective for long-term treatment of symptomatic obstructive HCM. [Extracted from the article]